Association among Dietary Flavonoids, Flavonoid Subclasses and Ovarian Cancer Risk: A Meta-Analysis by Xiaoli Hua (2558284)

“…In a subgroup analysis by flavonoid subtypes, the ovarian cancer risk was also decreased for isoflavones (<i>RR</i> = 0.67, 95% CI = 0.50–0.92) and flavonols (<i>RR</i> = 0.68, 95% CI = 0.58–0.80). …”

The <i>pdcB</i> switch contains an invertible promoter. by Leila M. Reyes Ruiz (6690206)

Knockdown of nr2f1a causes defects in zebrafish vascular development. by Bao-Jueng Wu (621818)

“…At the same stage ISVs are stalled at mid-somite in nr2f1a^e2i2 morphants (<b>D, F</b>). (<b>I</b>) Quantification of percentage of completed ISV shows a ∼50% increase compared to <i>nr2f1a</i> morphants (n = 26 in wt and n = 34 in nr2f1aMO) at 30 hpf. …”

Parity and Pancreatic Cancer Risk: A Dose-Response Meta-Analysis of Epidemiologic Studies by Hong-Bo Guan (464993)

“…</p><p>Conclusion</p><p>In summary, these findings suggest that higher parity is associated with a decreased risk of PC. Future large consortia or pooled studies are warranted to fully adjust for potential confounders to confirm this association.…”

S2 Data - by Tamara Mogilevski (14239682)

“…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”

Study protocol. by Tamara Mogilevski (14239682)

“…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”

S1 Data - by Tamara Mogilevski (14239682)

“…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”

Fig 11 - by Wan Noorul Hafilah Wan Ariffin (20796795)

Fig 12 - by Wan Noorul Hafilah Wan Ariffin (20796795)

Fig 13 - by Wan Noorul Hafilah Wan Ariffin (20796795)

Preliminary molecular characterization of a proinflammatory and nociceptive molecule from the Echinometra lucunter spines extracts by Juliana Mozer Sciani (4626790)

Antioxidant Carbocysteine Treatment in Obstructive Sleep Apnea Syndrome: A Randomized Clinical Trial by Kang Wu (160544)

“…The CPAP group also showed a decreased oxygen desaturation index and a significant increase in the mean oxygen saturation after treatment, but these increases were not observed in the carbocysteine group. …”

Chronic treatment with carvacrol improves passive avoidance memory in a rat model of Parkinson's disease by Hossein Haddadi (4895290)

“…The 6-OHDA-lesioned rats showed contralateral rotations towards the lesion side, which was accompanied by learning and memory deficits in a passive avoidance test and a decrease in tail withdrawal latency in a tail flick test at the end of week 6. …”

Vibration–induced enhancement of stick balancing skill as a function of vibration-induced amplitude lowering. by John G. Milton (223908)

“…Data is obtained from three subjects using three different vibration frequencies (15 Hz, 25 Hz, 50 Hz) on three different days. Relative survival is the same as defined in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0007427#pone-0007427-g003" target="_blank">Figure 3</a>. …”

PAMAM-DEN^CYS induces trafficking of ΔF508-CFTR to plasma membrane in CF cells. by Scott Mackenzie Brockman (4433614)

“…(A, right panel; C) Immunoblotting of total protein extracts from CFBE41o- cells treated with PAMAM-DEN or PAMAM-DEN^CYS shows a significant increase in ‘C form’ (p<0.05) in PAMAM-DEN^CYS treated cells. …”

Image3_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpeg by Heather A. Ogana (11774297)

“…Therefore, we evaluated four compounds (827171, 827032, 826941, and 825226), previously generated from a large Artemis targeted drug screen. A biochemical assay using a purified Artemis:DNA-PKcs complex shows that the Artemis inhibitors 827171, 827032, 826941, 825226 have nanomolar IC50 values for Artemis inhibition. …”

Image1_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpg by Heather A. Ogana (11774297)

“…Therefore, we evaluated four compounds (827171, 827032, 826941, and 825226), previously generated from a large Artemis targeted drug screen. A biochemical assay using a purified Artemis:DNA-PKcs complex shows that the Artemis inhibitors 827171, 827032, 826941, 825226 have nanomolar IC50 values for Artemis inhibition. …”

HBV Infection in Relation to Consistent Condom Use: A Population-Based Study in Peru by Antonio Bernabe-Ortiz (90790)

“…Consistent condom use was associated with decreased risk of anti-HBc. Findings from this study emphasize the need of primary prevention programs (vaccination) especially in the jungle population, and imply that condom use promotion might be a potential strategy to prevent HBV infection.…”

Granulocyte Colony-Stimulating Factor Reduces Fibrosis in a Mouse Model of Chronic Pancreatitis by Wey-Ran Lin (615284)

“…We aimed to test the effect of G-CSF on fibrosis in a mouse model of CP.</p><p>Methods</p><p>CP was induced in C57Bl/6J mice by consecutive cerulein injection (50 µg/kg/day, 2 days a week) for 6 weeks. …”

Image2_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpeg by Heather A. Ogana (11774297)

“…Therefore, we evaluated four compounds (827171, 827032, 826941, and 825226), previously generated from a large Artemis targeted drug screen. A biochemical assay using a purified Artemis:DNA-PKcs complex shows that the Artemis inhibitors 827171, 827032, 826941, 825226 have nanomolar IC50 values for Artemis inhibition. …”